Old Web
English
Sign In
Acemap
>
Paper
>
XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy.
XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy.
2021
Xuanzong Li
Bing Zou
Shijiang Wang
Linlin Wang
Jinming Yu
Keywords:
Mutant
Cancer research
Immunotherapy
KEAP1
Medicine
XPO1
STK11
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
0
Citations
NaN
KQI
[]